Hand-made biology by Petsko, Gregory A
But tonight, we shall hurl the gauntlet of science 
into the frightful face of death itself.
Young Frankenstein (1974)
It’s alive! It’s ALIVE! … Oh, in the name of God! 
Now I know what it feels like to BE God!
Frankenstein (1931)
Craig  Venter  would  never  be  Central  Casting’s  first 
choice to play Dr Frankenstein. And I can’t see Hamilton 
Smith  as  Igor,  either.  But  when  these  two  genome 
biologists  and  their  coworkers  announced,  in  the  May 
20th issue of Science, that they had ‘created’ a bacterium, 
one would have been forgiven for thinking, based on the 
language  they  used  and  the  turgid  -  even  hysterical  - 
reports in the press, that they were auditioning for the 
parts. Here is the opening paragraph of the account of 
their work in The Economist, a publication not custom-
arily given to hyperbole:
In the end there was no castle, no thunderstorm 
and definitely no hunchbacked cackling lab 
assistant. Nevertheless, Craig Venter, Hamilton 
Smith and their colleagues have done for real what 
Mary Shelley merely imagined. On May 20th, in 
the pages of Science, they announced that they had 
created a living creature.
But did they? Is their achievement ‘creation’ in the literal, 
and  Frankensteinian,  sense  of  the  word  (the  action  or 
process  of  bringing  something  into  existence),  or  is  it 
something else entirely? And if it is something else, is it 
still  as  monumental  as  some  people,  and  the  authors 
themselves, claim?
In case you were in a coma and missed it, here’s a brief 
summary of what they did. They took a ‘host’ strain, that 
of the small, free-living bacterium Mycoplasma capricolum, 
and  deleted  the  genes  for  its  own  restriction  enzymes 
(this would correspond to the cadaver in the Frankenstein 
tale). The restriction enzyme genes were deleted so that 
the host would not cleave the ‘foreign’ DNA they planned 
to  insert.  (The  equivalent  to  this  procedure  would  be 
immune suppressing a transplant recipient so that they 
would not reject the foreign organ.) Venter, Smith and 
colleagues  then  inserted  into  this  strain  a  completely 
synthetic chromosome (the ‘brain’) for the related strain 
Mycoplasma mycoides. In synthesizing the 1.08 million 
base pairs of this genome, the team at the J Craig Venter 
Institute  deliberately  deleted  14  genes  that  might  have 
conferred  pathogenicity  on  the  new  strain,  and  also 
inserted  into  the  DNA  sequence  a  set  of  watermarks: 
specifically  designed  segments  of  DNA  that  spell  out 
words  and  phrases.  The  watermarks  prove  that  the 
genome is synthetic, and identify the laboratory of origin. 
Encoded  in  the  watermarks  is  a  new  DNA  code  for 
writing words, sentences and numbers. In addition to the 
new code there is a web address to send emails to if you 
can decode it, plus the names of 46 authors and other key 
contributors to the work, and these three quotations: ’To 
live, to err, to fall, to triumph, to recreate life out of life’ - 
James Joyce; ‘See things not as they are, but as they might 
be’ - from the book, American Prometheus; and ‘What I 
cannot build, I cannot understand’ - Richard Feynman. 
After  about  30  generations,  there  was  no  trace  of  the 
original bacterial genome in the new organism (presu-
mably, it had been destroyed by the restriction enzymes 
encoded by the synthetic chromosome), and the proteins 
and other macromolecules in the cell were entirely those 
from the inserted DNA. That’s the achievement. What 
does it mean?
First, can we all agree that there is nothing surprising 
here? No one should have been amazed that this worked. 
Not only was it likely to work; it HAD to work if it was 
done  properly.  The  surprise  would  have  been  if  it 
HADN’T worked. In an interview given at the time of 
publication, Venter, a truly great scientist whose genius 
extends to a talent for self-promotion, said, ‘Really, it has 
changed  my  view  of  the  definition  of  life  and  how  it 
works.’ Which makes me want to ask him just what his 
view of the definition of life and how it works used to be, 
because it must have been remarkably naïve. This is no 
conceptual  breakthrough,  no  matter  what  language  is 
used to describe it.
Venter, who headed the private team that sequenced 
the human genome 10 years ago (along with the public 
effort  headed  by  Francis  Collins),  calls  the  result  a  © 2010 BioMed Central Ltd
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than  Frankenstein’s  monster  was  a  synthetic  human. 
‘Synthetic’ means a substance that is made by chemical 
synthesis,  often  in  imitation  of  a  natural  product.  The 
genome  that  Venter  and  Smith  inserted  into  their 
cadaverous host was synthetic, but the host was not. It 
was an actual bacterial cell, produced naturally. To have 
made a synthetic cell, Venter and Smith would have had 
to synthesize abiotically not only the DNA, but also all of 
the proteins, carbohydrates, lipids and other molecules 
that make up the cytoplasm and shell of the organism. 
They are a long way from doing that.
The  closest  analogy  to  what  they  did  is  not  Mary 
Shelley’s  fictional  mad  scientist  and  his  unfortunate 
creation;  it  is  a  technique  called  somatic  cell  nuclear 
transfer (SCNT), and it has been used for years. In SCNT 
(sometimes  referred  to  as  therapeutic  cloning),  the 
nucleus of a somatic cell is removed and the rest of the 
cell discarded. At the same time, the nucleus of a host egg 
cell is removed. The nucleus of the somatic cell is then 
inserted  into  the  denucleated  egg,  and  after  many  cell 
divisions, a blastocyst (early stage embryo) forms, which 
is a clone of the original somatic donor organism. This is 
the process used to clone Dolly the sheep, and nearly all 
other animals that have been cloned. The success of this 
procedure guaranteed that the Venter team’s procedure 
of reprogramming one bacterial cell with the DNA from 
another  would  work  if  done  properly.  The  major 
difference  is  that  they  used  a  synthetic  genome  and 
carried out their experiments in a bacterial host rather 
than  a  eukaryotic  one.  For  me,  what  they  did  is  not 
creating  life.  It’s  making  chromosomes  and  letting  the 
machinery  of  an  already  evolved  life  form  read  the 
sequence and produce the desired output.
So now that I have, I hope, convinced you that this is no 
big deal, let me convince you that it is actually a very big 
deal. No, Venter and Company did not create life - at 
least not in the sense that the phrase is normally used. 
But what they did do is pretty monumental nonetheless.
For  starters,  they  have  shown  that  it  is  possible  to 
synthesize functional chromosomes. That’s a formidable 
technical  achievement.  M.  mycoides  has  a  very  small 
genome, but the method they developed, of making the 
sequence in fragments and using the high rate of homolo-
gous recombination in budding yeast to assemble them, 
is clearly applicable to much larger genomes.
Second,  they  have  single-handedly  made  Systems 
Biology  into  a  viable  intellectual  discipline.  It  is  now 
possible to design organisms to test the predictions and 
models  from  that  ambitious  field  -  organisms  simple 
enough that the assumptions that go into the models may 
actually not be too bad. If I were the Systems Biology 
community,  I’d  be  buying  Venter  and  Smith  a  drink. 
Maybe lots of drinks.
But it’s the third thing they’ve done that impresses me 
the most, because I think it is going to be a game-changer 
for all of us. In taking the first step towards the con  struc-
tion of a truly synthetic cell, Venter and colleagues have 
also taken the first step towards making biology into an 
engineering science.
Engineers  design  things  and  then  build  them  out  of 
pre-made, usually standardized, parts. Smith and Venter 
didn’t quite do that, but they came closer than anyone 
has before, and they and others will come closer still, very 
soon.  It  won’t  be  long  until  simple  organisms  can  be 
designed and constructed, if not fully synthetically, then 
semi-synthetically  as  was  done  here  -  organisms  with 
novel and useful properties. The Systems Biology folks 
will learn how to do the designing, and the Venters of the 
world will then make organisms to order. To facilitate such 
engineering, it would be nice to have reliable software to 
design the collection of genes and pathways needed for a 
particular set of desired properties, plus a set of premade, 
standardized  parts  (genes  and  prepared  host  cells),  and 
there are people already starting to make both. In the end, 
designed organisms could churn out drugs like artemisinin 
(an antimalarial compound currently isolated from willow 
extract), or gobble up oil spills. Their uses will be limited 
only by our imaginations and our ability to predict what 
output a given set of parts will produce.
Engineers are problem-solvers and when engineering 
comes  to  biology  (or  is  it  the  other  way  around?),  we 
should be able to solve a number of very important ones. 
Unfortunately,  some  problems  are  military,  and  the 
solutions to these often involve making weapons. That’s 
just the way it is. The fear that this new science of hand-
made  biology  will  be  used  to  make  bioweapons  is 
overblown for now - the technology is too complex and 
expensive,  and  terrorists  can,  unfortunately,  manage 
quite well with much simpler instruments of death - but 
doubtless  at  some  point  in  the  future  some  group,  or 
rogue nation-state, will try. Prohibiting synthetic biology, 
or strangling it with regulations, is not the way to deal 
with  this  threat.  Experience  teaches  that  information 
cannot be confined, and in the end it is better to know 
what the forces of evil might do, so that we can plan our 
countermeasures from the beginning.
Something very much like this happened to chemistry 
in the past century. Using the science to make molecules 
became as important as fundamental discoveries in the 
structure  and  reactivity  of  matter.  That  change  didn’t 
diminish  the  centrality  of  chemistry  as  a  discipline;  it 
enhanced it. Of course, along with the plastics and the 
new drugs came nerve gas and high explosives. This loss 
of innocence can happen to biology, too. It probably will. 
But in the end, we will accept the risks in order to reap 
the benefits, like we did with atomic energy, and synthetic 
chemistry.
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they aren’t playing God either. What they’re really playing 
is Thomas Edison. There is no divinity in this work; quite 
the  opposite.  It’s  being  done  for  practical,  commercial 
reasons, and partly because of that there will be a lot of 
safeties built in, especially in the early days. The religious 
right  and  the  ethicists  and  the  neo-Luddites  and  the 
average  concerned  citizen  shouldn’t  worry  too  much 
about synthetic biology, at least not yet.
The ones who should worry are the synthetic chemists, 
because living organisms can make many polymers and 
drugs and novel materials faster, cheaper, and with more 
complexity and variety than chemists can. And what does 
the future hold for process chemistry when we can design 
our  organisms  to  fit  our  manufacturing  technology, 
instead of the other way around?
Yes,  if  I  were  a  synthetic  chemist  or  a  chemical 
engineer, I’d be worried. Actually, if I were a synthetic 
chemist or a chemical engineer, I’d be learning how to do 
synthetic biology.
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